Direct effects of protein S in ameliorating acute lung injury

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 12, 2009, Pages 2053-2063

  Takagi, T ^a   Taguchi, O ^a   Aoki, S ^a   Toda, M ^a   Yamaguchi, A ^a   Fujimoto, H ^a   Boveda Ruiz, D ^a   Gil Bernabe, P ^a   Ramirez, A Y ^a   Naito, M ^a   Yano, Y ^a   D'Alessandro Gabazza, C N ^a   Fujiwara, A ^a   Takei, Y ^a   Morser, J ^a,b   Gabazza, E C ^a  

^a MIE UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activated protein C; Anticoagulant; Cytokines; Lung injury; Proteases; Protein S

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN C; PROTEIN S; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; INFLAMMATION; MALE; MOUSE; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ANIMALS; BIOLOGICAL MARKERS; CYTOKINES; DRUG THERAPY, COMBINATION; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; PROTEIN C; PROTEIN S; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77449097920     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03642.x     Document Type: Article

References (32)

1. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005; 33: 319-27.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-49.
3. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369: 1553-64.
4. Brower RG, Ware LB, Berthiaume Y, Matthay MA. Treatment of ARDS. Chest 2001; 120: 1347-67.
5. Sapru A, Wiemels JL, Witte JS, Ware LB, Matthay MA. Acute lung injury and the coagulation pathway: potential role of gene polymorphisms in the protein C and fibrinolytic pathways. Intensive Care Med 2006; 32: 1293-303.
6. Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA. Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291: L307-11.
7. Gabazza EC, Taguchi O, Kamada H, Suzuki K. Progress in the understanding of protease-activated receptors. Int J Hematol 2004; 79: 117-22.
8. Esmon CT. The protein C pathway. Chest 2003; 124: 26S-32S.
9. Dahlbäck B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett 2005; 579: 3310-6.
10. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008; 112: 19-27.
11. Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004; 103: 1192-201.
12. Hackeng TM, Sere KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA 2006; 103: 3106-11.
13. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003; 4: 87-91.
14. Kask L, Trouw LA, Dahlbäck B, Blom AM. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J Biol Chem 2004; 279: 23869-73.
15. Webb JH, Blom AM, Dahlbäck B. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J Immunol 2002; 169: 2580-6.
16. Liu D, Guo H, Griffin JH, Fernández JA, Zlokovic BV. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation 2003; 107: 1791-6.
17. Hafizi S, Dahlbäck B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006; 273: 5231-44.
18. Taylor F, Chang A, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT. C4b-binding protein exacerbates the host response to Escherichia coli. Blood 1991; 78: 357-63.
19. Taylor FB Jr, Dahlback B, Chang AC, Lockhart MS, Hatanaka K, Peer G, Esmon CT. Role of free protein S and C4b binding protein in regulating the coagulant response to Escherichia coli. Blood 1995; 86: 2642-52.
20. Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, Shimizu S, Suzuki K, Adachi Y, Taguchi O. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 2001; 163: 1660-8.
21. Meyer KC, Zimmerman JJ. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993; 121: 654-61.
22. Nénan S, Boichot E, Planquois JM, Berna P, Hitier S, Bénard T, Lagente V, Bertrand CP. Effects of depletion of neutrophils or macrophages on the inflammatory response induced by metalloelastase (MMP-12) in mice airways. Eur J Pharmacol 2008; 579: 374-81.
23. Ko KW, Paul A, Ma K, Li L, Chan L. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res 2005; 46: 2586-94.
24. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol. 1997; 272(2 Pt 1):L197-202
25. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007; 35: 1821-8.
26. Thompson WD, Stirk CM, Melvin WT, Smith EB. Plasmin, fibrin degradation and angiogenesis. Nat Med 1996; 2: 493.
27. Lim YP, Bendelja K, Opal SM, Siryaporn E, Hixson DC, Palardy JE. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis 2003; 188: 919-26.
28. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia - a review. Crit Care Med 2006; 34: 871-7.
29. Ganopolsky JG, Castellino FJ. A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol 2004; 165: 1433-46.
30. Bernard GR. Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit Care Med 2003; 31: S85-93.
31. Suzuki K, Gabazza EC, Hayashi T, Taguchi O. Protective role of activated protein C in lung and airway remodeling. Crit Care Med 2004; 32: S262-5.
32. Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv L. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006; 203: 1891-901.